Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arixa Pharmaceuticals IncfiledCriticalArixa Pharmaceuticals Inc
Priority to ARP200103600ApriorityCriticalpatent/AR120862A1/en
Publication of AR120862A1publicationCriticalpatent/AR120862A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Las composiciones farmacéuticas comprenden amoxicilina y un derivado de avibactam y métodos para tratar infecciones bacterianas al utilizar las composiciones farmacéuticas. Las composiciones farmacéuticas pueden formularse para su administración oral y después de la administración oral proporcionar una cantidad terapéuticamente efectiva de amoxicilina y avibactam en el plasma de un paciente. Las composiciones y métodos farmacéuticos orales pueden utilizarse para tratar infecciones micobacterianas.The pharmaceutical compositions comprise amoxicillin and an avibactam derivative and methods of treating bacterial infections using the pharmaceutical compositions. Pharmaceutical compositions can be formulated for oral administration and after oral administration provide a therapeutically effective amount of amoxicillin and avibactam in the plasma of a patient. The oral pharmaceutical compositions and methods can be used to treat mycobacterial infections.
ARP200103600A2020-12-212020-12-21
COMBINATIONS OF AMOXICILLIN AND AVIBACTAM DERIVATIVES ADMINISTERED ORALLY TO TREAT MYCOBACTERIAL INFECTIONS
AR120862A1
(en)
Use of an oral transmucosal pharmaceutical composition comprising dexmedetomidine and a pharmaceutically acceptable salt and a pharmaceutically acceptable excipient to prepare a medicament useful for treating or preventing pain.
PHARMACEUTICAL COMPOSITIONS OF (R) -1- (2,2-DIFLUOROBENZO [D] [1,3] DIOXOL-5-IL) -N- (1- (2,3-DIHYDROXIPROPIL) -6-FLUORO-2- ( 1-HYDROXI-2-METHYLPROPAN-2-IL) -1H-INDOL-5-IL) CYCLOPROPANCARBOXAMIDE AND ADMINISTRATION OF THE SAME
Use of a topical composition comprising 3.75% imiquimod and a pharmaceutically acceptable carrier to prepare a medicament useful for treating genital or perianal warts.
PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN INHIBITING AGENT OF XANTINO OXIDASA USEFUL FOR THE CONTROL AND TREATMENT OF THE DROP, GOTOUS ARTHRITIS AND RELATED DISEASES
ORAL GALENIC FORMULATION INCLUDING KETOROLACO AND VITAMINS OF COMPLEX B, IN WHICH VITAMIN B6 IS IN AN EXTERNAL LAYER SEPARATED FROM THE REST OF ACTIVE PRINCIPLES
Pharmaceutical compositions comprising a combination formed by the antimicrobial agent CIPROFLOXACIN AND ANTIOXIDANT AGENT ASCORBIC ACID FOR THE TREATMENT OF INFECTIONS OF URINARY SYSTEM
Pharmaceutical composition comprising the combination of a selective cyclooxygenase 2 inhibitor and a carbamate derived from guaifenesin for the treatment of pain, inflammation and muscle contracture.